The Revolution of Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy

R Haraf, H Habib, A Masri - Canadian Journal of Cardiology, 2024 - Elsevier
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy
worldwide and causes significant morbidity and mortality. For decades, medical treatment …